When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Many diagnostic errors are associated with laboratory testing, and many of these are preventable. However, a reduction in testing-related diagnostic errors (TDE) is hindered by the absence of a well-defined relationship between diagnostic harm and the testing process (whether from laboratory or non-laboratory sources) as well as by a lack of relevant measures for evaluation. The goal of this paper is to review current models that describe the testing process, and then propose a different approach to facilitate the reduction of diagnostic errors and harm related to diagnostic testing. We then demonstrate how this approach can be used to develop measures that may improve patient outcomes and guide future research to reduce TDE. Finally, we highlight the need for collaboration between clinicians and laboratory physicians and scientists to achieve these goals. Diagnoses typically result from the patient history and physical. However, diagnostic testing is often used to confirm initial impressions or rule out alternatives, and at least 10% of all diagnoses are not considered final until clinical laboratory testing is complete.1 ,2 This number most likely underestimates the actual impact of testing on diagnosis. In the emergency room, clinical laboratory testing is ordered in more than 41% of all visits.3 Family physicians order tests in 29% of all patient visits, and general internists, in 38% of visits.4 These percentages would be even higher if the calculations were based only on the 33.9% of primary care visits that involve a new complaint.5 Advances in technology have also contributed to the increased importance of laboratory tests. In the past, laboratory tests were used to identify organ and system dysfunctions or diseases. While this is still true, testing nowadays is used to diagnose disease subtypes, as occurs when pathology reports of cancer are accompanied by tumour-specific and patient-specific …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonini, P., Plebani, M., Ceriotti, F., & Rubboli, F. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.691 · Cited by 850
Singh, H., Thomas, E. J., Sittig, D. F., Wilson, L., Espadas, D., Khan, M. M., & Petersen, L. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.07.027 · Cited by 160
The Impact of Peer Management on Test-Ordering Behavior
Neilson, E. G., Johnson, K. B., Rosenbloom, S. T., Dupont, W. D., Talbert, D., Giuse, D. A., Kaiser, A., Miller, R. A., & and the Resource Utilization Committee* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-3-200408030-00008 · Cited by 147
Cited by
The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149856 · Cited by 229
Cabitza, F., & Zeitoun, J.-D. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.07 · Cited by 72
“However, this sort of “rational” augmentation could exacerbate the reliance on imaging and laboratory tests, thus raising concerns about its impact on patient safety (37), clinical skills (38) and costs related to overuse.”
BackgroundPerformance specifications for the extra-analytical phases of laboratory testing: Why and how
Plebani, M. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.002 · Cited by 34
Maude, J. (2014) · Diagnosis · doi:10.1515/dx-2013-0009 · Cited by 29
“Since only 34% of visits to primary care are for a new complaint this means that, in reality, tests are probably ordered for almost every new visit [6].”
Background
Metadata
- Authors
- Epner, P. L., Gans, J. E., & Graber, M. L.
- Venue
- BMJ Quality & Safety
- Publisher
- BMJ
- Published
- 2013-08-16
- Volume
- 22
- Issue
- Suppl 2
- Pages
- ii6-ii10
- ISSN
- 1475-3898 (ISSN-L)
- 2044-5415
- 2044-5423
- OpenAlex
- W2103732084
- Cited by
- 125
- References
- 3
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. https://app.cochat.ai/papers/10.1136/bmjqs-2012-001621
- The paper
- Epner, P. L., Gans, J. E., & Graber, M. L. (2013). When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Quality & Safety. https://doi.org/10.1136/bmjqs-2012-001621
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.